Clinical Trial Update: Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt [Phase 4]

View source ↗

Summary

Phase IV trial in Egypt assessed the efficacy of alpha-lipoic acid for symptomatic diabetic polyneuropathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Eva Pharma | Conditions: Polyneuropathy, Diabetic | Phase 4 | Status: COMPLETED